BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25110100)

  • 1. Mathematical simulation of p53-Mdm2 protein biological system regulation.
    Voropaeva OF; Shokin YI; Nepomnyashchikh LM; Senchukova SR
    Bull Exp Biol Med; 2014 Aug; 157(4):535-8. PubMed ID: 25110100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.
    Huang C; Wu S; Ji H; Yan X; Xie Y; Murai S; Zhao H; Miyagishi M; Kasim V
    Sci Adv; 2017 Oct; 3(10):e1701383. PubMed ID: 29057323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2-mediated ubiquitylation: p53 and beyond.
    Marine JC; Lozano G
    Cell Death Differ; 2010 Jan; 17(1):93-102. PubMed ID: 19498444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical modeling of functioning of the p53-Mdm2 protein system.
    Voropaeva OF; Shokin YI; Nepomnyashchikh LM; Senchukova SR
    Bull Exp Biol Med; 2014 Jun; 157(2):291-4. PubMed ID: 24952502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic variants in the p53 pathway.
    Murphy ME
    Cell Death Differ; 2006 Jun; 13(6):916-20. PubMed ID: 16557270
    [No Abstract]   [Full Text] [Related]  

  • 8. p53-mediated control of gene expression via mRNA translation during Endoplasmic Reticulum stress.
    López I; Tournillon AS; Nylander K; Fåhraeus R
    Cell Cycle; 2015; 14(21):3373-8. PubMed ID: 26397130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of p53 in metabolism and invasion.
    Vousden KH
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):511-7. PubMed ID: 19442244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells.
    Kao CL; Hsu HS; Chen HW; Cheng TH
    Cancer Lett; 2009 Dec; 286(2):250-9. PubMed ID: 19560264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein S2 interplays with MDM2 to induce p53.
    Cho J; Park J; Shin SC; Kim JH; Kim EE; Song EJ
    Biochem Biophys Res Commun; 2020 Mar; 523(2):542-547. PubMed ID: 31928715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation.
    Tomiyasu H; Habara M; Hanaki S; Sato Y; Miki Y; Shimada M
    J Biol Chem; 2024 Apr; 300(4):107209. PubMed ID: 38519029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular bridging of aging and cancer: A CARF link.
    Cheung CT; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2010 Jun; 1197():129-33. PubMed ID: 20536841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.
    Tovar C; Rosinski J; Filipovic Z; Higgins B; Kolinsky K; Hilton H; Zhao X; Vu BT; Qing W; Packman K; Myklebost O; Heimbrook DC; Vassilev LT
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1888-93. PubMed ID: 16443686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer.
    Wu B; Chu X; Feng C; Hou J; Fan H; Liu N; Li C; Kong X; Ye X; Meng S
    Cancer Lett; 2015 Apr; 359(2):325-34. PubMed ID: 25637791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
    Nardinocchi L; Puca R; Givol D; D'Orazi G
    FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2: p53's lifesaver?
    Shmueli A; Oren M
    Mol Cell; 2007 Mar; 25(6):794-6. PubMed ID: 17386256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.